2 completed. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
Follow Hemosiderosis: new trials by email Literature Review of Hemosiderosis trials Research Report on Hemosiderosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration) Deferasirox - Beta-thalassemia Major, Hemosiderosis | Phase 4 | Completed | Novartis Pharmaceuticals | 233 | 2005-06-01 | 2011-08-31 |
| Efficacy Study in Removing Excess Iron From the Heart Ferriprox (deferiprone), Desferal (deferoxamine) - Thalassemia Major, Hemosiderosis | Phase 4 | Completed | ApoPharma | 60 | 2002-12-01 | 2016-01-05 |
Iron Overload (2) · beta-Thalassemia (2) · Hemochromatosis (1) · Thalassemia (1)
Anemia (2) · Anemia, Hemolytic (2) · Anemia, Hemolytic, Congenital (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Hemoglobinopathies (2) · Iron Metabolism Disorders (2) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2) · Metabolism, Inborn Errors (1) · Metal Metabolism, Inborn Errors (1) · Thalassemia (1)
Deferasirox (1) · Deferiprone (1) · Deferoxamine (1)
ApoPharma (1) · Novartis Pharmaceuticals (1)
Egypt (1) · Greece (1) · Italy (1) · Lebanon (1) · Oman (1) · Saudi Arabia (1) · Syria (1)
Antonio Piga, M.D. (1) · Markissia Karagiorga, M.D. (1) · Renzo Galanello, M.D. (1) · Vassilis Ladis, M.D. (1)